Form 4 for INCY Incyte
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-005896 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-01 | 2023-01-30 | INCY | Pasquale Maria E | EVP, GC | S - Sale+OE | $84.74 | -60.0K | 68.5K | -47% | -$5.09M |
| DM | 2023-02-01 | 2023-01-30 | INCY | Pasquale Maria E | EVP, GC | M - OptEx | $73.39 | +60.0K | 81.4K | +281% | +$4.41M |
| DM | 2023-02-01 | 2023-01-30 | INCY | Pasquale Maria E | EVP, GC | M - OptEx | $0.00 | -60.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-30 | S | D | 11,861 | $84.70 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 2 | Common | Common Stock | 2023-01-30 | M | A | 14,374 | $80.50 | 82,898 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-30 | S | D | 14,374 | $84.73 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 4 | Common | Common Stock | 2023-01-30 | M | A | 5,644 | $83.58 | 74,168 | D | — | — | |
| 5 | Common | Common Stock | 2023-01-30 | S | D | 5,644 | $85.07 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 6 | Common | Common Stock | 2023-01-30 | M | A | 4,842 | $74.78 | 73,366 | D | — | — | |
| 7 | Common | Common Stock | 2023-01-30 | S | D | 4,842 | $84.73 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. (F2) Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
| 8 | Common | Common Stock | 2023-01-30 | M | A | 11,861 | $72.27 | 80,385 | D | — | — | |
| 9 | Common | Common Stock | 2023-01-30 | S | D | 10,438 | $84.70 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 10 | Common | Common Stock | 2023-01-30 | M | A | 10,438 | $68.62 | 78,962 | D | — | — | |
| 11 | Common | Common Stock | 2023-01-30 | S | D | 12,865 | $84.69 | 68,524 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 12 | Common | Common Stock | 2023-01-30 | M | A | 12,865 | $65.36 | 81,389 | D | — | — | |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 4,842 | $0.00 | 0 | D | $74.78 · — to 2032-01-18 | 4,842 Common Stock | (F8) Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 12,865 | $0.00 | 0 | D | $65.36 · — to 2028-04-08 | 12,865 Common Stock | (F3) Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting on April 9, 2019 and the remainder vesting monthly over three years. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 5,644 | $0.00 | 0 | D | $83.58 · — to 2031-07-01 | 5,644 Common Stock | (F7) Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. |
| 16 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 11,861 | $0.00 | 0 | D | $72.27 · — to 2029-01-03 | 11,861 Common Stock | (F5) Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |
| 17 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 14,374 | $0.00 | 0 | D | $80.50 · — to 2030-01-16 | 14,374 Common Stock | (F6) Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2020 and the remainder vesting monthly over three years. |
| 18 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-01-30 | M | D | 10,438 | $0.00 | 0 | D | $68.62 · — to 2028-07-01 | 10,438 Common Stock | (F4) Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |